announcement, page-24

re: up 22% new high ready to take off Good enthusiasm imorgante, but still a bit of overhang to go from Perth from the original shell holders of southpointe. That is a short-term thing though. This stock is one of the best biotechs out there by a long margin. Do the rough numbers - Medtronic put cash in at a valuation of the technology about 3 x the current market cap. Don't be surprised to see Poly Novo spun out, with CSIRO being a major holder which will unlock major value. Next will be orthopedics where they can do a deal with Medtronic again or J and J. Now they have the validation from Medtronic, the next deal with be bigger and fatter from a cash perspective. Very very good CEO in place - experienced dealmaker.